Cargando…
Estimating cancer survival and prevalence with the Medical-Insurance-System-based Cancer Surveillance System (MIS-CASS): An empirical study in China
BACKGROUND: We aimed to establish a new approach for surveillance of cancer prevalence and survival in China, based on the Medical-Insurance-System-based Cancer Surveillance System (MIS-CASS). METHODS: We constructed a standard procedure for data collection, cleaning, processing, linkage, verificati...
Autores principales: | Tian, Hongrui, Hu, Yanjun, Li, Qingxiang, Lei, Liang, Liu, Zhen, Liu, Mengfei, Guo, Chuanhai, Liu, Fangfang, Liu, Ying, Pan, Yaqi, dos-Santos-Silva, Isabel, He, Zhonghu, Ke, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921516/ https://www.ncbi.nlm.nih.gov/pubmed/33718848 http://dx.doi.org/10.1016/j.eclinm.2021.100756 |
Ejemplares similares
-
The Incidence of Lymphoma in Beijing: Comparing Results from MIS-CASS (2019) and Beijing Cancer Registry (2017)
por: Tian, Hongrui, et al.
Publicado: (2021) -
Identification of cancer patients using claims data from health insurance systems: A real-world comparative study
por: Tian, Hongrui, et al.
Publicado: (2019) -
Estimating cancer incidence based on claims data from medical insurance systems in two areas lacking cancer registries in China
por: Tian, Hongrui, et al.
Publicado: (2020) -
Development and validation of a questionnaire-based risk scoring system to identify individuals at high risk for gastric cancer in Chinese populations
por: Zhou, Ren, et al.
Publicado: (2021) -
Health-seeking behavior and barriers to treatment of patients with upper gastrointestinal cancer detected by screening in rural China: real-world evidence from the ESECC trial
por: Wang, Hui, et al.
Publicado: (2021)